Life Science Network
The Life Science Network is the destination for life science professionals who wish to network, communicate, share ideas and connect with others. Our group is composed of more than 15,000 executives, scientists, entrepreneurs, investors and media across biotechnology, pharmaceutical, medical technology, diagnostics and research communities. Most importantly, the Life Science Network brings no industry agenda. You won't find us pushing promotion disguised as learning. We come together for easy communication, to make new connections, find new ways to collaborate, and help one another find the latest jobs or partnering opportunities. Join us!
June 24, 2016
This week: The FDA approves the first clinical trial for a Zika vaccine, scientists report the reversal of cognitive impairment in Alzheimer’s patients, researchers get closer to unveiling the “holy grail” of breast cancer prevention, and a new report suggests mammals escaped end-Cretaceous extinction by just four species.
June 17, 2016
This week: Scientists use CRISPR to record bacteria’s molecular history and synthetic biologists report a new approach for engineering malaria drugs from tobacco plants. Additionally, a new study shows the promise of ultrasound technology in improving chemotherapy delivery through the blood-brain barrier.
June 10, 2016
This week: plans to synthesize the human genome were announced after a secret Harvard meeting, and scientists find a new mutation that causes Parkinson’s disease. Also: Vermont paves the way with a new law that requires pharmaceutical companies to justify drug price hikes, and researchers report the inhibiting capacities of a family of human proteins against the Zika virus.